CVS Health plans to enter primary care by end of 2022CVS Health said that it plans to acquire or take a stake in a primary care company by the end of the year. Hy-Vee dietitians hosting healthy back-to-school events in AugustHy-Vee dietitians are hosting a series of programs and workshops focused on helping kids and families prepare for the upcoming school year with healthy recipes. Marinus launches Ztalmy Ztalmy is the only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder in patients 2 years of age and older. Fresenius Kabi intros generic Tepadina Generic Tepadina has multiple indications, including for the treatment of patients with adenocarcinoma of the breast or ovary. Optum to offer lower-cost Sanofi insulin for uninsured people with diabetes People living with diabetes who do not have insurance will pay $35 for a 30-day supply of Sanofi insulins. GSK obtains FDA approval for new indication for Benlysta Benlysta is now the first and only biologic approved for adults and children who have lupus or lupus nephritis. Kinney Drugs completes installation of medication collection kiosks in all 75 NY locations The installation of these units brings Kinney to 83 kiosks in total. Aurobindo receives FDA OK for generic Letairis Generic Letairis is indicated for the treatment of pulmonary arterial hypertension (WHO Group 1) and also is used in combination with tadalafil. Apotex offers generic Eliquis in Canada Apotex's apixaban is an oral anticoagulant indicated for the prevention and treatment of harmful blood clots. Prunelax debuts gummies Prunelax Gummies aims to help consumers relieve occasional constipation and help maintain bowel regularity, the company said. First Previous 117 118 119 120 121 Next Last